Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Oliver Weigert, Harald Stein et al.|The Lancet Oncology|2015Cited by 613
The promise of organ and tissue preservation to transform medicineSebastian Giwa, Mehmet Toner, Jedediah Lewis et al.|Nature Biotechnology|2017Cited by 530
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell TransplantationAlex F. Herrera, Philippe Armand, Matthew Mei et al.|Journal of Clinical Oncology|2016Cited by 187
Targeting minimal residual disease: a path to cure?Marlise R. Luskin, David M. Weinstock, Mark A. Murakami et al.|Nature reviews. Cancer|2018Cited by 164
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibitionOliver Weigert, David M. Weinstock|The Journal of Experimental Medicine|2012Cited by 162